The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia

Ultrasound in Obstetrics and Gynecology

Volumn 21, Issue 2, 2003, Pages 165-169

  Florio, P ^a   Reis, F M ^b   Pezzani, I ^c   Luisi, S ^a   Severi, F M ^a   Petraglia, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Activin; Doppler; Inhibin; Pre eclampsia; Predictive value

Indexed keywords

ACTIVIN A; INHIBIN A;

ADULT; ARTICLE; CONTROLLED STUDY; DEVICE; DISEASE MARKER; DOPPLER FLOWMETER; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROGNOSIS; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; UTERINE ARTERY;

ACTIVINS; ADULT; BLOOD FLOW VELOCITY; FEMALE; HUMANS; INHIBIN-BETA SUBUNITS; INHIBINS; LASER-DOPPLER FLOWMETRY; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RHEOLOGY; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL; UTERUS;

EID: 0345269938     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.29     Document Type: Article

References (21)

1. Reis FM, D'Antona D, Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 2002; 23: 230-257.
2. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53-56.
3. Schneider EP, Schulman H. Hypertension. In Doppler Ultrasound in Obstetrics and Gynecology, Copel JA, Reed KL (eds). Raven Press: New York, 1995; 147-155.
4. Campbell S, Pearce JM, Hackett G, Cohen-Overbeek T, Hernandez C. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol 1986; 68: 649-653.
5. Ochi H, Matsubara K, Kusanagi Y, Taniguchi H, Ito M. Significance of a diastolic notch in the uterine artery flow velocity waveform induced by uterine embolisation in the pregnant ewe. Br J Obstet Gynaecol 1998; 105: 1118-1121.
6. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000; 96: 559-564.
7. Chien PF, Arnott N, Gordon A, Owen P, Khan KS. How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. Br J Obstet Gynaecol 2000; 107: 196-208.
8. Petraglia F, De Vita D, Gallinelli A, Aguzzoli L, Genazzani AR, Romero R, Woodruff TK. Abnormal concentration of maternal serum activin-A in gestational diseases. J Clin Endocrinol Metab 1995; 80: 558-561.
9. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997; 349: 1285-1288.
10. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999; 180: 1131-1137.
11. Aquilina J, Barnett A, Thompson O, Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol 1999; 181: 131-136.
12. D'Antona D, Reis FM, Benedetto C, Evans LW, Groome NP, de Kretser DM, Wallace EM, Petraglia F. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 2000; 165: 157-162.
13. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, Ledger W, Groome N, Redman CW. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000; 15: 1640-1645.
14. Lambert-Messerlian GM, Silver HM, Petraglia F, Luisi S, Pezzani I, Maybruck WM, Hogge WA, Hanley-Yanez K, Roberts JM, Neveux LM, Canick JA. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin A as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Investig 2000; 7: 170-174.
15. Grobman WA, Wang EY. Serum levels of activin A and inhibin A and the subsequent development of preeclampsia. Obstet Gynecol 2000; 96: 390-394.
16. Aquilina J, Thompson B, Thilaganathan B, Harrington K. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol 2001; 17: 477-484.
17. National High Blood Pressure Education Program. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
18. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 1996; 148: 267-279.
19. Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganesan TS, Baird DT, McNeilly AS. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 1994; 40: 717-723.
20. Petraglia F, Hartmann B, Luisi S, Florio P, Santuz M, Kirchengast S, Santuz M, Genazzani AD, Genazzani AR. Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea. Fertil Steril 1998; 70: 907-912.
21. Richardson WS, Wilson MC, Guyatt GH, Cook DJ, Nishikawa J. Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence-based medicine working group. JAMA 1999; 281: 1214-1219.